Literature DB >> 8426447

Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities.

E A Belongia1, M T Osterholm, J T Soler, D A Ammend, J E Braun, K L MacDonald.   

Abstract

OBJECTIVE: Escherichia coli O157:H7 infection can cause hemorrhagic colitis and hemolytic uremic syndrome. Since 1988 the Minnesota Department of Health has carried out surveillance for this infection. To assess the occurrence of person-to-person transmission within day-care facilities, we investigated facilities where an infected child attended after onset of symptoms.
DESIGN: Parents of children less than 5 years old with E coli O157:H7 infection were interviewed from July 1988 through December 1989. If the child attended day care after onset, stool cultures were obtained from other children in attendance and their parents were interviewed. If there was presumptive evidence of ongoing E coli O157:H7 transmission in a facility, all preschool children were excluded from attending day-care facilities until two consecutive stool cultures were negative.
RESULTS: Sixty-eight cases of E coli O157:H7 infection were identified in Minnesota during the 18-month period, including 29 cases identified through investigations at nine day-care facilities. There was evidence of person-to-person transmission in all nine facilities. The median number of infected children per facility was two (range, two to 18), and the median attack rate was 22% (range, 3% to 38%). The median age of the primary case at each facility was 26 months (range, 12 to 59 months). There was no evidence of further transmission at facilities where children were temporarily excluded until two consecutive stool cultures were negative.
CONCLUSION: Person-to-person transmission of E coli O157:H7 is common when infected preschool children attend day care while symptomatic. The number of unrecognized day-care outbreaks in the United States may be substantial due to the lack of routine testing for this pathogen in stool cultures, the absence of public health surveillance in many regions, and incomplete follow-up of infected children. Temporary exclusion of all children was an effective control strategy in this population, but additional investigations are needed to determine the optimal intervention.

Entities:  

Mesh:

Year:  1993        PMID: 8426447

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  39 in total

1.  Evaluation of a real-time PCR kit for detecting Escherichia coli O157 in bovine fecal samples.

Authors:  James L Bono; James E Keen; Laura C Miller; James M Fox; Carol G Chitko-McKown; Michael P Heaton; William W Laegreid
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

2.  Therapy: Azithromycin and decolonization after HUS.

Authors:  Michael E Seifert; Phillip I Tarr
Journal:  Nat Rev Nephrol       Date:  2012-05-01       Impact factor: 28.314

3.  Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood.

Authors:  P C Rowe
Journal:  Can J Infect Dis       Date:  1995-03

4.  Prevalence of Escherichia coli O157 in Saskatchewan cattle: characterization of isolates by using random amplified polymorphic DNA PCR, antibiotic resistance profiles, and pathogenicity determinants.

Authors:  Sinisa Vidovic; Darren R Korber
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

5.  Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture.

Authors:  H Karch; C Janetzki-Mittmann; S Aleksic; M Datz
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 6.  Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.

Authors:  Jessica Keithlin; Jan Sargeant; M Kate Thomas; Aamir Fazil
Journal:  Foodborne Pathog Dis       Date:  2013-11-27       Impact factor: 3.171

7.  Control of enterohaemorrhagic Escherichia coli infection: the need for a network involving microbiological laboratories and clinical and public health institutions.

Authors:  H Karch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

Review 8.  Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.

Authors:  B E Mahon; P M Griffin; P S Mead; R V Tauxe
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

9.  Association of Escherichia coli O157:H7 tir polymorphisms with human infection.

Authors:  James L Bono; James E Keen; Michael L Clawson; Lisa M Durso; Michael P Heaton; William W Laegreid
Journal:  BMC Infect Dis       Date:  2007-08-24       Impact factor: 3.090

10.  Primary and secondary cases in Escherichia coli O157 outbreaks: a statistical analysis.

Authors:  Kate G Snedeker; Darren J Shaw; Mary E Locking; Robin J Prescott
Journal:  BMC Infect Dis       Date:  2009-08-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.